An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol
Zika virus (ZIKV) infection may adversely affect pregnancies of women living with HIV (WLHIV). Because no study to date has focused on maternal and child effects of HIV and ZIKV co-infection in pregnant women, we undertook the International Prospective Cohort Study of HIV and Zika in Infants and Pre...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-07-01
|
| Series: | Frontiers in Global Women's Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgwh.2021.574327/full |
| _version_ | 1818889964657573888 |
|---|---|
| author | Ann Aschengrau Marisa M. Mussi-Pinhata John Moye Nahida Chakhtoura Kunjal Patel Paige L. Williams Brad Karalius Patricia A. Garvie Dina Monte Frances Whalen Jill Lebov George R. Seage |
| author_facet | Ann Aschengrau Marisa M. Mussi-Pinhata John Moye Nahida Chakhtoura Kunjal Patel Paige L. Williams Brad Karalius Patricia A. Garvie Dina Monte Frances Whalen Jill Lebov George R. Seage |
| author_sort | Ann Aschengrau |
| collection | DOAJ |
| description | Zika virus (ZIKV) infection may adversely affect pregnancies of women living with HIV (WLHIV). Because no study to date has focused on maternal and child effects of HIV and ZIKV co-infection in pregnant women, we undertook the International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP). The aims of this two-phase study of pregnant women and their infants are to compare the incidence of ZIKV infection among pregnant women with and without HIV infection and to determine the risk of adverse maternal and child outcomes associated with ZIKV/HIV co-infection at clinical sites in Brazil, Puerto Rico, and the continental United States. Phase I was designed to enroll pregnant women/infant pairs who were: (1) infected with HIV only, (2) infected with ZIKV only, (3) infected with HIV and ZIKV, and (4) not infected with either HIV or ZIKV. A key goal of this phase was to assess the feasibility of enrolling 200 women/infant pairs within a year, with a target of 150 WLHIV, 50 HIV-uninfected women, and a minimum of 20 who were co-infected with HIV and ZIKV. If the feasibility of Phase I proved successful, Phase II would enroll up to 1,800 additional pregnant women/infant pairs to the same four groups. Enrolled women in both phases were to be followed throughout their pregnancy and up to 6 weeks post-partum. Infants were also to be followed for 1 year after birth. To date, Phase 1 data collection and follow-up have been completed. Delineation of possible harmful effects of HIV/ZIKV co-infection will allow the formulation of standard-of-care recommendations to minimize adverse effects but enable the continuation of preventive HIV therapy. Furthermore, while the prospective HIV ZIP study was developed before the COVID pandemic, it is especially relevant today since it can be easily adapted to provide critically important information on the impact of COVID-19 infection or other still unrecognized new agents among pregnant women and their offspring worldwide. |
| first_indexed | 2024-12-19T17:17:23Z |
| format | Article |
| id | doaj.art-31e73ef5acec46bd8fc1ee580a1e2535 |
| institution | Directory Open Access Journal |
| issn | 2673-5059 |
| language | English |
| last_indexed | 2024-12-19T17:17:23Z |
| publishDate | 2021-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Global Women's Health |
| spelling | doaj.art-31e73ef5acec46bd8fc1ee580a1e25352022-12-21T20:12:49ZengFrontiers Media S.A.Frontiers in Global Women's Health2673-50592021-07-01210.3389/fgwh.2021.574327574327An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study ProtocolAnn Aschengrau0Marisa M. Mussi-Pinhata1John Moye2Nahida Chakhtoura3Kunjal Patel4Paige L. Williams5Brad Karalius6Patricia A. Garvie7Dina Monte8Frances Whalen9Jill Lebov10George R. Seage11Department of Epidemiology, Boston University School of Public Health, Boston, MA, United StatesDepartment of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, BrazilMaternal Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United StatesMaternal Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United StatesDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United StatesDepartments of Biostatistics and Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United StatesDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United StatesResearch Department, Children's Diagnostic and Treatment Center, Fort Lauderdale, FL, United StatesWestat, Rockville, MD, United StatesWestat, Rockville, MD, United StatesResearch Triangle Institute International, Research Triangle Park, NC, United StatesDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United StatesZika virus (ZIKV) infection may adversely affect pregnancies of women living with HIV (WLHIV). Because no study to date has focused on maternal and child effects of HIV and ZIKV co-infection in pregnant women, we undertook the International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP). The aims of this two-phase study of pregnant women and their infants are to compare the incidence of ZIKV infection among pregnant women with and without HIV infection and to determine the risk of adverse maternal and child outcomes associated with ZIKV/HIV co-infection at clinical sites in Brazil, Puerto Rico, and the continental United States. Phase I was designed to enroll pregnant women/infant pairs who were: (1) infected with HIV only, (2) infected with ZIKV only, (3) infected with HIV and ZIKV, and (4) not infected with either HIV or ZIKV. A key goal of this phase was to assess the feasibility of enrolling 200 women/infant pairs within a year, with a target of 150 WLHIV, 50 HIV-uninfected women, and a minimum of 20 who were co-infected with HIV and ZIKV. If the feasibility of Phase I proved successful, Phase II would enroll up to 1,800 additional pregnant women/infant pairs to the same four groups. Enrolled women in both phases were to be followed throughout their pregnancy and up to 6 weeks post-partum. Infants were also to be followed for 1 year after birth. To date, Phase 1 data collection and follow-up have been completed. Delineation of possible harmful effects of HIV/ZIKV co-infection will allow the formulation of standard-of-care recommendations to minimize adverse effects but enable the continuation of preventive HIV therapy. Furthermore, while the prospective HIV ZIP study was developed before the COVID pandemic, it is especially relevant today since it can be easily adapted to provide critically important information on the impact of COVID-19 infection or other still unrecognized new agents among pregnant women and their offspring worldwide.https://www.frontiersin.org/articles/10.3389/fgwh.2021.574327/fullZika virushuman immunodeficiency viruspregnancyinfantsadverse outcomes |
| spellingShingle | Ann Aschengrau Marisa M. Mussi-Pinhata John Moye Nahida Chakhtoura Kunjal Patel Paige L. Williams Brad Karalius Patricia A. Garvie Dina Monte Frances Whalen Jill Lebov George R. Seage An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol Frontiers in Global Women's Health Zika virus human immunodeficiency virus pregnancy infants adverse outcomes |
| title | An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol |
| title_full | An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol |
| title_fullStr | An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol |
| title_full_unstemmed | An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol |
| title_short | An International Prospective Cohort Study of HIV and Zika in Infants and Pregnancy (HIV ZIP): Study Protocol |
| title_sort | international prospective cohort study of hiv and zika in infants and pregnancy hiv zip study protocol |
| topic | Zika virus human immunodeficiency virus pregnancy infants adverse outcomes |
| url | https://www.frontiersin.org/articles/10.3389/fgwh.2021.574327/full |
| work_keys_str_mv | AT annaschengrau aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT marisammussipinhata aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT johnmoye aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT nahidachakhtoura aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT kunjalpatel aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT paigelwilliams aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT bradkaralius aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT patriciaagarvie aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT dinamonte aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT franceswhalen aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT jilllebov aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT georgerseage aninternationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT annaschengrau internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT marisammussipinhata internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT johnmoye internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT nahidachakhtoura internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT kunjalpatel internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT paigelwilliams internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT bradkaralius internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT patriciaagarvie internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT dinamonte internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT franceswhalen internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT jilllebov internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol AT georgerseage internationalprospectivecohortstudyofhivandzikaininfantsandpregnancyhivzipstudyprotocol |